Table 3. The proportion of early and total apoptotic SW620 cells as analysed by flow cytometry.
| Apoptotic activity | t/h | ||
|---|---|---|---|
| 24 | 48 | 72 | |
| Early | N(cell)/% | ||
| Control | (10.51±2.50)ab | (7.57±0.69)d | (9.72±2.50)ab |
| Doxorubicin | (13.56±0.41)b | (19.13±2.24)c | (29.03±4.21)a |
| FA fraction | (32.11±1.16)d | (48.10±3.46)e | (52.24±1.09)e |
| Total | |||
| Control | (15.44±2.42)a | (16.77±3.14)ab | (24.72±7.58)b |
| Doxorubicin | (20.22±1.33)ab | (36.62±4.11)c | (63.18±2.64)a |
| FA fraction | (79.86±1.24)e | (95.85±2.46)f | (97.95±1.35)f |
Data are presented as mean value±S.D. of three replicates. Mean values with a different letter in superscript are significantly different (p≤0.05; Duncan's multiple range test)